Some of the best links we picked up around the internet
Allogene Therapeutics has activated the first clinical sites in a pivotal Phase 2 trial of cema-cel as first line consolidation treatment for large...
In this clinical update, we look at recent advances in two clinical-stage gene-editing programmes. Editas Medicine's sickle cell disease candidate...